Milae Bioresources Co. Ltd (218150) — Cash Flow-to-Debt Ratio
Milae Bioresources Co. Ltd (218150) has a Cash Flow-to-Debt Ratio of -0.03x as of March 2026, meaning its operating cash flow of ₩-492.41 Million could theoretically repay 0% of its total liabilities (₩17.71 Billion) in one year. Check Milae Bioresources Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Milae Bioresources Co. Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Milae Bioresources Co. Ltd across 10 annual periods. Also explore Milae Bioresources Co. Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Milae Bioresources Co. Ltd (2016–2025)
Year-by-year debt coverage analysis for Milae Bioresources Co. Ltd. For market capitalisation and broader financial context, see Milae Bioresources Co. Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | ₩4.40 Billion | ₩16.21 Billion | ▲ +671.0% |
| 2024 | -0.05x | ₩-966.33 Million | ₩20.32 Billion | ▼ -110.9% |
| 2023 | 0.43x | ₩3.23 Billion | ₩7.43 Billion | ▲ +459.7% |
| 2022 | 0.08x | ₩1.19 Billion | ₩15.35 Billion | ▼ -41.4% |
| 2021 | 0.13x | ₩2.98 Billion | ₩22.50 Billion | ▲ +34.6% |
| 2020 | 0.10x | ₩848.31 Million | ₩8.61 Billion | ▼ -75.5% |
| 2019 | 0.40x | ₩3.56 Billion | ₩8.86 Billion | ▲ +576.9% |
| 2018 | -0.08x | ₩-477.75 Million | ₩5.66 Billion | ▼ -112.7% |
| 2017 | 0.66x | ₩4.18 Billion | ₩6.30 Billion | ▲ +1228.3% |
| 2016 | 0.05x | ₩76.65 Million | ₩1.53 Billion | — |